CKS2 and neoplasm: Clustering based on MSN, TBX3, LSM3, CKS2, MRPL1, and MRPS23 expression identified four tumor groups, for which patients of group 1 and 4, with high expression of LSM3, CKS2, MRPL11, and MRPS23 and, in general, low expression of MSN and TBX3 compared to group 2 and 3, had the lowest survival probability (Figure 5B).